A/RES/58/236 5. Urges Member States to intensify national efforts and international cooperation in the implementation of the Declaration of Commitment in order to meet the goals and targets contained therein based on national plans, where they exist, and, in particular, where gaps have been identified in the report of the Secretary-General by, inter alia: (a) Providing stronger and more visible leadership in response to the epidemic; (b) Creating an environment that encourages the engagement of and partnerships with all stakeholders, including civil society, people living with HIV/AIDS, marginalized and vulnerable groups, cultural and faith-based organizations, non-governmental organizations, traditional health practitioners, the private sector, international institutions and the media; (c) Strengthening policies and programmes for combating HIV/AIDS, including those relating to the protection and promotion of all human rights and fundamental freedoms for all, including eliminating stigmas and discrimination against people living with and/or affected by HIV/AIDS, ensuring gender equality, assisting orphans and children and expanding access to treatment, care and support; (d) Building and scaling up a comprehensive response to achieve broad multisectoral coverage for prevention, care, treatment and support and recognizing the need to seriously address impact mitigation issues, in particular in the worst affected countries, and specifically within this context: (i) Intensifying prevention measures, especially those directed at vulnerable groups, in particular women and young persons, bearing in mind that prevention is the mainstay of the national, regional and international response; (ii) Expanding access to treatment, in a progressive and sustainable manner, including the prevention and treatment of opportunistic diseases and the effective use of antiretroviral medication; (iii) Improving the provision of care and support to those infected and affected by HIV/AIDS, including orphans; (iv) Mitigating the social and economic impact of the epidemic; (v) Promoting access to low-cost pharmaceutical products; and (vi) Strengthening health-care systems programmes into current health services; effective and drugs and integrating related HIV/AIDS (vii) Strengthening HIV/AIDS surveillance and systems for evaluating programme effectiveness; (e) Strengthening pharmaceutical policies and practices, including those applicable to generic drugs and intellectual property regimes, in order to further promote innovation and the development of domestic industries consistent with international law; (f) Intensifying training and research initiatives or programmes to strengthen the capacities of Governments to manage the epidemic; (g) Sharing experiences and exchanging information on key areas of intervention, such as prevention, the provision of care and support for HIV/AIDSinfected persons and the treatment of HIV/AIDS-related conditions; 4